RGRomina A. Gisonno

Romina A. Gisonno

*This is an algorithmically generated author record based on publicly available information.

Romina A. Gisonno has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • M. Alejandra Tricerri

    Universidad Nacional de La Plata

    7 shared publications
  • Nahuel A. Ramella

    Instituto de Investigaciones Bioquímicas de La Plata "Prof. Dr. Rodolfo R. Brenner" (INIBIOLP), CONICET, CCT-La Plata, La Plata, Buenos Aires, Argentina; Facultad de Ciencias Médicas, Universidad Nacional de La Plata (UNLP), La Plata, Buenos Aires, Argentina

    5 shared publications
  • Gabriela S. Finarelli

    Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET, La Plata, Buenos Aires, Argentina

    3 shared publications
  • Gisela M. Gaddi

    Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET, La Plata, Buenos Aires, Argentina

    3 shared publications
  • M. Fernanda Cortez

    Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), CONICET, La Plata, Buenos Aires, Argentina

    3 shared publications
  • Nahuel A. Ramella

    Instituto de Investigaciones Bioquímicas de La Plata (INIBIOLP), Argentina

    3 shared publications

Latest Publications

  • Hereditary Amyloidosis: insights into a fibrinogen A variant diagnosis PC14 (#153)

    by Maria Alejandra, Elizabeth R., Romina A., Martín C., Marianela Santana, Silvana A., Elsa Nucifora, Maria Adela, María C., Nahuel A.

    **Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER

  • Evolutionary and structural constraints influencing apolipoprotein A-I amyloid behavior

    by Romina A. Gisonno, Tomas Masson, Nahuel A. Ramella, Exequiel E. Barrera, Víctor Romanowski, M. Alejandra Tricerri

    Apolipoprotein A-I (apoA-I) has a key function in the reverse cholesterol transport. However, aggregation of apoA-I single point mutants can lead to hereditary amyloid pathology. Although several studies have tackled the biophysical and structural consequences introduced by these mutations, there is little information addressing the relationship between the evolutionary and structural features that contribute to the amyloid behavior of apoA-I. We combined evolutionary studies, in silico mutagenesis and molecular dynamics (MD) simulations to provide a comprehensive analysis of the conservation and pathogenic role of the aggregation-prone regions (APRs) present in apoA-I. Sequence analysis demonstrated that among the four amyloidogenic regions described for human apoA-I, only two (APR1 and APR4) are evolutionary conserved across different species of Sarcopterygii. Moreover, stability analysis carried out with the FoldX engine showed that APR1 contributes to the marginal stability of apoA-I. Structural properties of full-length apoA-I models suggest that aggregation is avoided by placing APRs into highly packed and rigid portions of its native fold. Compared to silent variants extracted from the gnomAD database, the thermodynamic and pathogenic impact of amyloid mutations showed evidence of a higher destabilizing effect. MD simulations of the amyloid variant G26R evidenced the partial unfolding of the alpha-helix bundle with the concomitant exposure of APR1 to the solvent, suggesting an insight into the early steps involved in its aggregation. Our findings highlight APR1 as a relevant component for apoA-I structural integrity and emphasize a destabilizing effect of amyloid variants that leads to the exposure of this region.


  • Open Access

    Dataset of the construction and characterization of stable biological nanoparticles

    by Romina A. Gisonno, M. Alejandra Tricerri, Marina C. Gonzalez, Horacio A. Garda, Nahuel A. Ramella, Ivo Díaz Ludovico


  • Open Access

    Data regarding the sensibility to proteolysis of a natural apolipoprotein A-I mutant.

    by Gisela M. Gaddi, Romina A. Gisonno, Silvana A. Rosú, M. Fernanda Cortez, Gabriela S. Finarelli, Nahuel A. Ramella, M. Alejandra Tricerri

  • Open Access

    Understanding the role of apolipoproteinA-I in atherosclerosis. Post-translational modifications synergize dysfunction?

    by Ivo Díaz Ludovico, Romina A. Gisonno, Marina C. Gonzalez, Horacio A. Garda, Nahuel A. Ramella, M. Alejandra Tricerri

    Background The identification of dysfunctional human apolipoprotein A-I (apoA-I) in atherosclerotic plaques suggests that protein structure and function may be hampered under a chronic pro inflammatory scenario. Moreover, the fact that natural mutants of this protein elicit severe cardiovascular diseases (CVD) strongly indicates that the native folding could shift due to the mutation, yielding a structure more prone to misfold or misfunction. To understand the events that determine the failure of apoA-I structural flexibility to fulfill its protective role, we took advantage of the study of a natural variant with a deletion of the residue lysine 107 (K107del) associated with atherosclerosis. Methods Biophysical approaches, such as electrophoresis, fluorescence and spectroscopy were used to characterize proteins structure and function, either in the native conformation or under oxidation or intramolecular crosslinking. Results K107del structure was more flexible than the protein with the native sequence (Wt) but interactions with artificial membranes were preserved. Instead, structural restrictions by intramolecular crosslinking impaired the Wt and K107del lipid solubilization function. In addition, controlled oxidation decreased the yield of the native dimer conformation for both variants. Conclusions We conclude that even though mutations may alter protein structure and spatial arrangement, the highly flexible conformation compensates the mild shift from the native folding. Instead, post translational apoA-I modifications (probably chronic and progressive) are required to raise a protein conformation with significant loss of function and increased aggregation tendency. General Significance The results learnt from this variant strength a close association between amyloidosis and atherosclerosis. Highlights -Oxidation is clue to induce protein misfolding -Natural mutation does not seem critical as a sole reason to determine pathogenicity -Atherosclerosis and amyloidosis are closely related -Intramolecular crosslinking restrains protein flexibility and function

  • Structural analysis of a natural apolipoprotein A-I variant (L60R) associated with amyloidosis

    by Gisela M. Gaddi, Romina A. Gisonno, Silvana A. Rosú, Lucrecia M. Curto, Eduardo D. Prieto, Guillermo R. Schinella, Gabriela S. Finarelli, M. Fernanda Cortez, Letizia Bauzá, Esteban E. Elías, et al.


  • Fibrillar conformation of an apolipoprotein A-I variant involved in amyloidosis and atherosclerosis

    by Romina A. Gisonno, Eduardo D. Prieto, Juan P. Gorgojo, Lucrecia M. Curto, M. Eugenia Rodriguez, Silvana A. Rosú, Gisela M. Gaddi, Gabriela S. Finarelli, M. Fernanda Cortez, Guillermo R. Schinella, et al.


  • Open Access

    N-terminal mutants of human apolipoprotein A-I: structural perturbations associated to protein misfolding

    by Gisela M. Gaddi, Romina A. Gisonno, Silvana A. Rosú, Lucrecia M. Curto, Esteban E. Elías, Eduardo D. Prieto, Guillermo R. Schinella, Gabriela S. Finarelli, M. Fernanda Cortez, Nahuel A. Ramella, et al.

    Since the early description of different human apolipoprotein A-I variants associated to amyloidosis, the reason that determines its deposition inducing organ failure has been under research. To shed light into the events associated to protein aggregation, we studied the effect of the structural perturbations induced by the replacement of a Leucine in position 60 by an Arginine as it occurs in the natural amyloidogenic variant (L60R). Circular dichroism, intrinsic fluorescence measurements and assays of binding to ligands indicate that L60R is more unstable, more sensitive to proteolysis and interacts with sodium dodecyl sulfate (a model of negative lipids) more than the protein with the native sequence and other natural variant tested, involving a replacement of a Trytophan by and Arginine in the amino acid 50 (W50R). In addition, the small structural rearrangement observed under physiological pH leads to the release of tumor necrosis factor α and interleukin-lβ from a model of macrophages. Our results strongly suggest that the chronic disease may be a consequence of the loss in the native conformation which alters the equilibrium among native and cytotoxic proteins conformation.